CN116234900A - 用于增加干细胞功能的组合物和方法 - Google Patents

用于增加干细胞功能的组合物和方法 Download PDF

Info

Publication number
CN116234900A
CN116234900A CN202180063424.0A CN202180063424A CN116234900A CN 116234900 A CN116234900 A CN 116234900A CN 202180063424 A CN202180063424 A CN 202180063424A CN 116234900 A CN116234900 A CN 116234900A
Authority
CN
China
Prior art keywords
urolithin
composition
vitamin
cells
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180063424.0A
Other languages
English (en)
Chinese (zh)
Inventor
N·万尼尼
G·库科斯
M·吉罗特拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Ludwig Cancer Research
Original Assignee
Societe des Produits Nestle SA
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Ludwig Cancer Research filed Critical Societe des Produits Nestle SA
Publication of CN116234900A publication Critical patent/CN116234900A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202180063424.0A 2020-09-28 2021-09-28 用于增加干细胞功能的组合物和方法 Pending CN116234900A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20198620.5 2020-09-28
EP20198620 2020-09-28
PCT/EP2021/076654 WO2022064061A1 (en) 2020-09-28 2021-09-28 Compositions and methods for increasing stem cell function

Publications (1)

Publication Number Publication Date
CN116234900A true CN116234900A (zh) 2023-06-06

Family

ID=72665073

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180063424.0A Pending CN116234900A (zh) 2020-09-28 2021-09-28 用于增加干细胞功能的组合物和方法

Country Status (8)

Country Link
US (1) US20240010981A1 (cg-RX-API-DMAC7.html)
EP (1) EP4217471A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023543149A (cg-RX-API-DMAC7.html)
CN (1) CN116234900A (cg-RX-API-DMAC7.html)
AU (1) AU2021348257A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023005370A2 (cg-RX-API-DMAC7.html)
CA (1) CA3188629A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022064061A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023237544A1 (en) * 2022-03-22 2024-10-31 Amazentis Sa Compositions

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101172140A (zh) * 2007-09-11 2008-05-07 珍奥集团股份有限公司 促进造血干细胞增殖与血红蛋白合成的营养组合物
CN105838675A (zh) * 2016-06-07 2016-08-10 广东万海细胞生物科技有限公司 一种造血干细胞无血清培养基
US20160348065A1 (en) * 2015-05-28 2016-12-01 Shenzhen Fulixin Health Industry Development Limited Culture medium for hematopoeitic stem cells and the applications thereof as well as the stem cells culture method
US20190008883A1 (en) * 2015-12-24 2019-01-10 Amazentis Sa Compositions comprising nicotinamide riboside and a urolithin
WO2020148445A1 (en) * 2019-01-18 2020-07-23 Société des Produits Nestlé S.A. Agents and methods for increasing stem cell function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723315A (en) 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CZ297278B6 (cs) 1996-08-07 2006-10-11 Darwin Discovery Limited Deriváty hydroxamové a karboxylové kyseliny a jejich pouzití
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
EP2995948A1 (en) * 2014-09-09 2016-03-16 Ecole Polytechnique Federale de Lausanne (EPFL) Methods and compounds useful in hematopoietic stem cell medicine
CN113613663B (zh) * 2019-03-29 2024-09-03 雀巢产品有限公司 用于增加t细胞功能的组合物和方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101172140A (zh) * 2007-09-11 2008-05-07 珍奥集团股份有限公司 促进造血干细胞增殖与血红蛋白合成的营养组合物
US20160348065A1 (en) * 2015-05-28 2016-12-01 Shenzhen Fulixin Health Industry Development Limited Culture medium for hematopoeitic stem cells and the applications thereof as well as the stem cells culture method
US20190008883A1 (en) * 2015-12-24 2019-01-10 Amazentis Sa Compositions comprising nicotinamide riboside and a urolithin
CN105838675A (zh) * 2016-06-07 2016-08-10 广东万海细胞生物科技有限公司 一种造血干细胞无血清培养基
WO2020148445A1 (en) * 2019-01-18 2020-07-23 Société des Produits Nestlé S.A. Agents and methods for increasing stem cell function

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICOLA VANNINI等: "The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance", 《CELL STEM CELL》, vol. 24, no. 3, 7 March 2019 (2019-03-07), pages 405 - 418 *

Also Published As

Publication number Publication date
EP4217471A1 (en) 2023-08-02
JP2026090303A (ja) 2026-06-02
BR112023005370A2 (pt) 2023-05-09
US20240010981A1 (en) 2024-01-11
AU2021348257A1 (en) 2023-03-02
CA3188629A1 (en) 2022-03-31
WO2022064061A1 (en) 2022-03-31
JP2023543149A (ja) 2023-10-13

Similar Documents

Publication Publication Date Title
JP7677893B2 (ja) 幹細胞機能を向上させるための薬剤及び方法
JPH08511935A (ja) 選択的細胞増殖
WO2020201076A2 (en) Compositions and methods for increasing t cell function
AU2017414804B2 (en) Selection and use of umbilical cord cell fractions suitable for transplantation
AU2018270407B2 (en) Selection and use of umbilical cord cell fractions suitable for transplantation
CN116391031A (zh) 用于增加干细胞功能的组合物和方法
US20240010981A1 (en) Compositions and methods for increasing stem cell function
HK40096626A (en) Compositions and methods for increasing stem cell function
HK40095240A (en) Compositions and methods for increasing stem cell function
CN117202903A (zh) 用于增加干细胞功能的尿石素
HK40104930A (en) Urolithin for increasing stem cell function
HK40058827A (en) Agents and methods for increasing stem cell function
CA3063674C (en) Selection and use of umbilical cord cell fractions suitable for transplantation
HK40063758B (en) Compositions and methods for increasing t cell function
HK40063758A (en) Compositions and methods for increasing t cell function

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40095240

Country of ref document: HK